Knowledge and attitude toward proton radiotherapy among oncology patients: a multi-center, cross-sectional study.

IF 3 4区医学 Q2 ONCOLOGY

Future oncology Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI:10.1080/14796694.2024.2383169

Wenjuan Xie, Honglian Wang, Qian Sun, Yuanyuan Wang, Yang Wang, Hui Chen, Xiangxia Liu

{"title":"Knowledge and attitude toward proton radiotherapy among oncology patients: a multi-center, cross-sectional study.","authors":"Wenjuan Xie, Honglian Wang, Qian Sun, Yuanyuan Wang, Yang Wang, Hui Chen, Xiangxia Liu","doi":"10.1080/14796694.2024.2383169","DOIUrl":null,"url":null,"abstract":"Aim: To explore the knowledge and attitude among oncology patients toward proton radiotherapy.Materials & methods: This cross-sectional study was performed using self-designed questionnaire.Results: Based on 546 valid questionnaires, mean knowledge and attitude scores of 3.4 ± 3.6 (range: 0-12) and 31.1 ± 3.5 (range: 10-50) were observed. Multivariate analysis demonstrated that higher education (p = 0.021), higher monthly income (p = 0.005), and proton radiotherapy history (p < 0.001) were independently associated with higher knowledge scores. Higher knowledge (p = 0.020), older age (p = 0.030), not smoking (p = 0.032) and medication use (p = 0.035) were independently associated with higher attitude scores.Conclusion: Oncology patients have insufficient knowledge and negative attitude toward proton radiotherapy, which might be affected by their age, education, income, proton radiotherapy history, employment, smoking and medication use.","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508946/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2024.2383169","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Aim: To explore the knowledge and attitude among oncology patients toward proton radiotherapy.Materials & methods: This cross-sectional study was performed using self-designed questionnaire.Results: Based on 546 valid questionnaires, mean knowledge and attitude scores of 3.4 ± 3.6 (range: 0-12) and 31.1 ± 3.5 (range: 10-50) were observed. Multivariate analysis demonstrated that higher education (p = 0.021), higher monthly income (p = 0.005), and proton radiotherapy history (p < 0.001) were independently associated with higher knowledge scores. Higher knowledge (p = 0.020), older age (p = 0.030), not smoking (p = 0.032) and medication use (p = 0.035) were independently associated with higher attitude scores.Conclusion: Oncology patients have insufficient knowledge and negative attitude toward proton radiotherapy, which might be affected by their age, education, income, proton radiotherapy history, employment, smoking and medication use.

查看原文本刊更多论文

肿瘤患者对质子放疗的认识和态度：一项多中心横断面研究。

目的：探讨肿瘤患者对质子放射治疗的认识和态度。材料与方法：采用自行设计的问卷进行横断面研究。研究结果根据 546 份有效问卷，观察到知识和态度的平均得分分别为 3.4 ± 3.6（范围：0-12）和 31.1 ± 3.5（范围：10-50）。多变量分析表明，教育程度较高（p = 0.021）、月收入较高（p = 0.005）、质子放疗史（p = 0.020）、年龄较大（p = 0.030）、不吸烟（p = 0.032）和使用药物（p = 0.035）与较高的态度评分独立相关。结论肿瘤患者对质子放疗的认识不足，态度消极，这可能受年龄、教育程度、收入、质子放疗史、就业、吸烟和用药等因素的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future oncology ONCOLOGY-

CiteScore

5.40

自引率

3.00%

发文量

335

审稿时长

4-8 weeks

期刊介绍： Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.